MOUNTAIN VIEW, Calif. (AP) _ ChemoCentryx Inc. (CCXI) on Friday reported fourth-quarter net income of $39.7 million, after reporting a loss in the same period a year earlier.
The Mountain View, California-based company said it had profit of 80 cents per share.
The biopharmaceutical company posted revenue of $56.3 million in the period.
For the year, the company reported net income of $17.9 million, or 36 cents per share, swinging to a profit in the period. Revenue was reported as $82.5 million.
ChemoCentryx shares have risen 83 percent since the beginning of the year. The stock has risen 63 percent in the last 12 months.